JO3046B1 - اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها. - Google Patents

اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.

Info

Publication number
JO3046B1
JO3046B1 JOP/2008/0099A JOP20080099A JO3046B1 JO 3046 B1 JO3046 B1 JO 3046B1 JO P20080099 A JOP20080099 A JO P20080099A JO 3046 B1 JO3046 B1 JO 3046B1
Authority
JO
Jordan
Prior art keywords
menthyldibenzo
chiloro
thiazepin
dihydro
amino
Prior art date
Application number
JOP/2008/0099A
Other languages
English (en)
Inventor
Sansone Matthew
Original Assignee
Transf Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738742&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3046(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transf Pharmaceuticals Inc filed Critical Transf Pharmaceuticals Inc
Application granted granted Critical
Publication of JO3046B1 publication Critical patent/JO3046B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

يتعلق الاختراع الحالي بأشكال متعددة polymorph)) جديدة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هبتانونك S,S- ثنائي أوكسيد) (7-[(3-chiloro-6, 11-dihydro-6-menthyldibenzo[c , f ][1,2] thiazepin-11-YL)AMINO ] heptanoic acid S,S-dioxide). موصوفة هنا زيصف هنا الاختراع أيضا تركيبات دوائية (pharmaceutical compositions) جديدة تشمل واحدا أو أكثر من الأشكال المتعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هبتانونك S,S- ثنائي أوكسيد) (7-[(3-chiloro-6, 11-dihydro-6-menthyldibenzo[c , f ][1,2] thiazepin-11-YL)AMINO ] heptanoic acid S,S-dioxide), طرقmethod)) تصنيعها و طرق المعالجة المتعلقة بها
JOP/2008/0099A 2007-03-05 2008-03-05 اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها. JO3046B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89294707P 2007-03-05 2007-03-05

Publications (1)

Publication Number Publication Date
JO3046B1 true JO3046B1 (ar) 2016-09-05

Family

ID=39738742

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2008/0099A JO3046B1 (ar) 2007-03-05 2008-03-05 اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.

Country Status (11)

Country Link
US (1) US8367656B2 (ar)
EP (1) EP2137157A4 (ar)
JP (1) JP2010520298A (ar)
AR (1) AR065602A1 (ar)
CA (1) CA2679936C (ar)
CL (1) CL2008000653A1 (ar)
JO (1) JO3046B1 (ar)
PE (2) PE20090534A1 (ar)
TW (1) TWI436988B (ar)
UY (1) UY30952A1 (ar)
WO (1) WO2008109577A1 (ar)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198268B2 (en) * 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
US10624902B1 (en) 2017-08-08 2020-04-21 James Peter Morrissette Dietary supplement
KR20200091395A (ko) * 2017-09-27 2020-07-30 페도라 파마슈티칼스 인코포레이티드 디아자비시클로옥탄 유도체의 결정형 및 그의 제조 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
JPS535661B2 (ar) * 1972-03-07 1978-03-01
CA995213A (fr) 1972-03-16 1976-08-17 Charles Malen Procede de preparation de derives tricycliques
FR2594827B1 (fr) * 1986-02-21 1988-05-20 Adir Nouveau derive tricyclique denomme acide ((chloro-3 methyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazepine (1,2) yl-11 amino)-5 pentazoique, son procede de preparation et les compositions pharmaceutiques qui le contiennent
FR2716623B1 (fr) * 1994-02-25 1996-08-23 Adir Utilisation d'un dérivé tricyclique pour l'obtention de médicaments destinés au traitement des troubles mnémo-cognitifs.
GB9624615D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Chrystallisation process
DE60001054T2 (de) * 1999-02-04 2003-07-24 Wyeth, Madison Trizyclische pyridin n-oxide vasopressin agonisten
BR0209433A (pt) * 2001-05-05 2004-08-03 Accentus Plc Método para realizar cristalização, e, aparelho
US6683072B1 (en) * 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia

Also Published As

Publication number Publication date
PE20090534A1 (es) 2009-05-03
US20080221081A1 (en) 2008-09-11
TWI436988B (zh) 2014-05-11
US8367656B2 (en) 2013-02-05
AR065602A1 (es) 2009-06-17
EP2137157A1 (en) 2009-12-30
CA2679936A1 (en) 2008-09-12
JP2010520298A (ja) 2010-06-10
TW200846331A (en) 2008-12-01
UY30952A1 (es) 2008-09-30
CA2679936C (en) 2017-07-11
PE20120574A1 (es) 2012-05-23
CL2008000653A1 (es) 2008-10-24
EP2137157A4 (en) 2010-12-15
WO2008109577A1 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
PT1913001E (pt) (r)-n-metilnaltrexona, processos para a sua síntese e sua utilização farmacêutica
WO2006086562A3 (en) Phenylazetidinone derivatives
TW200716646A (en) (S)-N-methylnaltrexone
TW200612892A (en) Novel compounds
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
UA105151C2 (uk) Антитіла проти ангіопоетину-2 людини
IL204732A (en) @@@@@ - Diplooro - @@ - Deoxy @ tetrahydro uridines, preparations containing them and their use in making @ drugs
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MXPA05009015A (es) Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2006124748A3 (en) Multicyclic compounds and methods of their use
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
WO2008136865A3 (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2008027600A3 (en) Imatinib compositions
TW200730518A (en) Crystalline forms of docetaxel and processes for their preparation
TW200738659A (en) Novel compounds
WO2004106322A3 (en) Polymorphs of aripiprazole
WO2007109799A3 (en) Polymorphs of eszopiclone malate
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
TW200734306A (en) Novel compounds, their preparation and use
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents